Antibody Engineering and Therapeutics ASIA

World-renowned scientists sharing the latest technologies, RandD and clinical data to fast-track your next-generation therapeutics towards commercial success.

7 Conference Session Themes:
- Novel Engineering and Discovery Strategies
- ADCs/Antibody-Drug Conjugates
- Bispecific Antibodies and Multi-Functional Biologics
- Immuno-Oncology
- Preclinical and Clinical Case Studies
- Delivery Strategies and Crossing/Penetrating Biological Barriers
- Engineering Strategies for TCR and CAR T Cell Therapies

Speakers: Sally Ward, PhD, Professor, Texas AandM University Health Science Center and University of Southampton, United Kingdom, Shohei Koide, PhD, Professor of Biologics Design, Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, USA, Paul W.H.I. Parren, PhD, EVP and Head of RandD, Lava Therapeutics and Professor, Leiden University Medical Center, The Netherlands, Tomoyuki Igawa, PhD, CEO and Research Head, Global Biologics Leader, Chugai Pharmabody Research Pte. Ltd., Singapore, Robert Mabrey, PhD, Head of Global Biologics, Takeda, USA
 

Others Details

Time: 8:00 am - 5:00 pm